NASDAQ:CMND - Nasdaq - CA1850534027 - Common Stock - Currency: USD
1.06
-0.05 (-4.5%)
The current stock price of CMND is 1.06 USD. In the past month the price decreased by -25.87%. In the past year, price decreased by -22.06%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 66.89 | 824.51B | ||
JNJ | JOHNSON & JOHNSON | 16.69 | 401.33B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 26.18 | 386.95B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 21.41 | 240.28B | ||
MRK | MERCK & CO. INC. | 12.39 | 239.09B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 14.56 | 228.26B | ||
PFE | PFIZER INC | 8.59 | 151.49B | ||
SNY | SANOFI-ADR | 14.24 | 148.55B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 53.59 | 123.97B | ||
GSK | GSK PLC-SPON ADR | 8.29 | 81.62B | ||
ZTS | ZOETIS INC | 28.78 | 76.29B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 33.71 | 47.88B |
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 15 patent families, including 27 granted patents and 24 pending applications. The portfolio spans a range of jurisdictions, including the United States, Europe, India, and China.
CLEARMIND MEDICINE INC
101-1220 West 6Th Avenue
Vancouver BRITISH COLUMBIA CA
Employees: 0
Company Website: https://www.clearmindmedicine.com/
Investor Relations: http://www.clearmindmedicine.com/investors
Phone: 16042601566
The current stock price of CMND is 1.06 USD. The price decreased by -4.5% in the last trading session.
The exchange symbol of CLEARMIND MEDICINE INC is CMND and it is listed on the Nasdaq exchange.
CMND stock is listed on the Nasdaq exchange.
CLEARMIND MEDICINE INC (CMND) has a market capitalization of 4.64M USD. This makes CMND a Nano Cap stock.
CLEARMIND MEDICINE INC (CMND) currently has 0 employees.
CLEARMIND MEDICINE INC (CMND) has a support level at 1.03 and a resistance level at 1.31. Check the full technical report for a detailed analysis of CMND support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CMND does not pay a dividend.
CLEARMIND MEDICINE INC (CMND) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.99).
The outstanding short interest for CLEARMIND MEDICINE INC (CMND) is 6.81% of its float. Check the ownership tab for more information on the CMND short interest.
ChartMill assigns a fundamental rating of 1 / 10 to CMND. Both the profitability and financial health of CMND have multiple concerns.
Over the last trailing twelve months CMND reported a non-GAAP Earnings per Share(EPS) of -1.99. The EPS increased by 95.76% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -72.42% | ||
ROE | -169.09% | ||
Debt/Equity | 0.01 |